Canaccord Starts Pulse Biosciences (PLSE) at Buy

June 4, 2026 6:09 AM

Canaccord analyst William Plovanic initiates coverage on Pulse Biosciences (NASDAQ: PLSE) with a Buy rating and a price target of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found